- Report
- April 2025
- 50 Pages
Global
From €2502EUR$2,650USD£2,146GBP
Moxastine is a respiratory drug used to treat asthma and other respiratory conditions. It is a long-acting beta-agonist (LABA) that works by relaxing the muscles of the airways, allowing more air to flow in and out of the lungs. It is usually taken in combination with an inhaled corticosteroid (ICS) to reduce inflammation in the airways. Moxastine is available in both tablet and inhaler form.
Moxastine is a widely used drug in the respiratory market, with many generic and branded versions available. It is often prescribed as a first-line treatment for asthma, and is also used to treat chronic obstructive pulmonary disease (COPD). It is generally well-tolerated, with few side effects.
In the market for respiratory drugs, Moxastine is a popular choice due to its effectiveness and affordability. It is available from many pharmaceutical companies, including GlaxoSmithKline, Merck, and Novartis. Show Less Read more